Maharashtra FDA launches prosecution against Trisis Ventures for non compliance to drugs act

The Maharashtra Food and Drug Administration (FDA) has launched prosecution against Trisis Ventures in Judicial Magistrate First Class (JMFC) Court, Bhiwandi for manufacturing disinfectant without license. This according to FDA officials is in contravention to the provision of Section 18 (c) of Drugs and Cosmetics (D&C) Act, 1940. Thane FDA team led by Drugs Inspector A A Raskar seized stock worth of Rs.11.11 crore of disinfectant Virkon S from a godown in Bhiwandi. The said disinfectant brand was manufactured in Baddi, Himachal Pradesh without licence. According to D&C Act 1940 under section 18 (C), any person who violates it and sells drugs without a valid license as required under clause C of section 18 shall be punishable with imprisonment for a term which shall not be less than one year but which may extend to three years and with fine which shall not be less than five thousand rupees. In a series of crackdown for violation of drug, the state drug regulator recently also detected an online illegal abortion drug racket. As a part of the crackdown, the state FDA has revealed that Medical Termination of Pregnancy (MTP) pills which is a scheduled drug was traded online in contravention to the law of the land. MTP is a schedule H drug and can be taken only against the prescription of a qualified gynaecologist. MTP Kit is a set of two essential abortion medicines -Mifepristone and Misoprostol which performs medical pregnancy termination (non-surgical embryo expel from womb) and should be taken only under the supervision and prescription of a gynaecologist. This is the latest in the series of such cases where offenders used to stock and sell MTP kits in a clandestine manner without a license and trade it online. FDA has booked offenders under different sections of Drug and Magic Remedies (DMR) Act, Essential Commodities (EC) Act and D&C Act.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!